|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/417 | (2006.01) |
| A61K 31/417 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 45/00 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/00 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 31/4184 | (2013.01) | ||
| A61K 31/713 | (2013.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3658141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18770099.2 |
| Date of filing the European patent application | 2018-07-24 | |
| (97) | Date of publication of the European application | 2020-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/NL2018/050515 |
| Date | 2018-07-24 |
| (87) | Number | WO 2019/022600 |
| Date | 2019-01-31 |
| (30) | Number | Date | Country code |
| 2019333 | 2017-07-24 | NL | |
| 2020938 | 2018-05-15 | NL |
| (72) |
RAABEN, Matthijs , NL
SCHEEREN, Ferenc Alexander , NL
LOGTENBERG, Meike Emma Willemijn , NL
BRUMMELKAMP, Thijn Reinout , NL
SCHUMACHER, Antonius Nicolaas Maria , NL
LEUSEN, Jeannette Henrica Wilhelmina , NL
|
| (73) |
Stichting Het Nederlands Kanker Instituut-
Antoni van Leeuwenhoek Ziekenhuis ,
Plesmanlaan 121, 1066 CX Amsterdam,
NL
Academisch Ziekenhuis Leiden h.o.d.n. LUMC , Albinusdreef 2, 2333 ZA Leiden, NL |
| (54) | TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPALPHA - CD47 INTERACTION |
| TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPALPHA - CD47 INTERACTION |